Medtronic buys MacroPore product line for $21 million:
This article was originally published in Clinica
Medtronic is to purchase San Diego, California-based MacroPore Biosurgery's Craniomaxillofacial/neurosurgical fixation product line for $21m in cash. Medtronic (Minneapolis, Minnesota) has been distributing the products for almost three years. The companies have also extended an existing co-development and supply agreement for spinal implants from 2005 to 2012. Neuer Markt-listed MacroPore will pay $4m to Medtronic for a waiver on the first rights to distribute MacroPore TS resorbable film product line in certain markets. MacroPore says the deals enable it to lower its operating costs, focus increasingly on biologics and invest in new market opportunities.
You may also be interested in...
Abbott is launching a second test to detect COVID-19. The diagnostics giant announced on 27 March the release of a rapid, point-of-care test that can deliver results within five minutes.
President Trump on 27 March finally pulled the trigger on using his powers under the Defense Production Act, forcing General Motors Co. to manufacture medical ventilators. The only thing is, GM is already doing that.
Theradaptive's “paint-like” regenerative therapeutic can be applied to any device to promote bone regrowth or regenerate tissue.